Mass spectrometry imaging (MSI) is capable of detection and identification of diverse classes of compounds in brain tissue sections, whereas simultaneously mapping their spatial distributions.
| INTRODUCTION
The ability to capture and visualize spatial distributions of biomolecules such as proteins, peptides, lipids, and metabolites within biological systems is fundamental to furthering their understanding and drive advances in fields such as medical diagnostics (Neubert & Walch, 2013; Schubert, Weiland, Baune, & Hoffmann, 2016) . Recent technological advancements in instrumentation and software have made mass spectrometry imaging (MSI), an analytical technique capable of detecting and characterizing a wide variety of molecular species while simultaneously mapping their spatial distributions, a viable and promising tool for this purpose. MSI platforms have undergone rapid development, and MSI now offers the possibility of providing detailed chemical information down to subcellular spatial resolutions (Zavalin et al., 2012) . This ability of simultaneously gathering chemical and spatial information from precise coordinates along a biological tissue section is helping applications of MSI in fields such as the pharmaceutical industry and clinical diagnostics (Buchberger, DeLaney, Johnson, & Li, 2018; Gowda et al., 2008) . MSI is now being applied in fields such as neurology and neuropsychopharmacology, helping provide insight into debilitating neurological diseases, such as Parkinson's and Alzheimer's, as well as traumatic brain injuries (Braidy et al., 2014; Shariatgorji, Svenningsson, & Andren, 2014; Woods et al., 2013) .
Given that more than half of the dry weight of the human brain consists of lipids, and the role lipids play in signaling pathways, their importance in neurological disease states is under investigation (Di Paolo & Kim, 2011) .
Secondary ion mass spectrometry (SIMS) and matrix-assisted laser desorption ionization-mass spectrometry (MALDI-MS) are the most extensively studied and broadly used MSI platforms. In a typical SIMS experiment, a focused primary ion beam is rastered across a tissue surface, imparting enough energy into the surface to cause desorption and formation of secondary ions. Among many other applications, this technique has demonstrated successful imaging of lipids in mouse brain tissue, as well as drugs used to treat neurological disorders (Sjovall, Lausmaa, & Johansson, 2004; Todd, Schaaff, Chaurand, & Caprioli, 2001; Touboul et al., 2004) . In a MALDI-MS experiment, a UV-absorbing matrix is deposited onto a sample, such as a tissue section. A laser is then rastered over the sample surface and absorption of incident laser light by the matrix leads to desorption and ionization of the material within the sample. These ions are then analyzed by the mass spectrometer (Caprioli, Farmer, & Gile, 1997) . This method has led to remarkably successful detection and imaging of proteins, peptides, lipids, and metabolites from biological tissues (Hutchinson et al., 2005; Jackson et al., 2007; Kertesz et al., 2008; Miura et al., 2010; Seeley, Oppenheimer, Mi, Chaurand, & Caprioli, 2008) . The broad detection capabilities offered by MALDI-MSI can be attributed to the array of possible matrix choices, with many matrices favoring ionization of certain molecules or molecular classes.
While MALDI has irrefutably laid the foundation for MSI, it has also suffered from inherent limitations. For example, the requirement of matrix deposition for efficient ionization of analytes can lead to undesirable effects such as analyte diffusion and inhomogeneous crystal formation (Baluya, Garrett, & Yost, 2007; Goodwin, 2012; Thomas, Charbonneau, Fournaise, & Chaurand, 2012) . Both of these issues can contribute to a reduction in achievable spatial resolution, arguably the most important parameter in MSI. Inhomogeneous crystallization in particular can lead to the creation of "hot-spots," so that apparent ion distributions are not representative of their natural distributions (Alexandrov, 2012) . Lastly, vacuum stability is a concern for some MALDI matrices. Given the generally long acquisition times required for MSI experiments, sublimation (and possibly redeposition) of matrix in the vacuum of the MALDI source can lead to contamination of the source, loss of signal, and inaccurate apparent molecular distributions (Potocnik, Porta, Becker, Heeren, & Ellis, 2015) .
Several matrix-free ionization platforms, including desorption/ionization on silicon, nanostructure-initiator mass spectrometry, and some ambient ionization approaches, such as desorption electrospray ionization and laser ablation electrospray ionization, have been developed in an effort to overcome these issues and reduce the sample preparation requirements (Nemes & Wei, Buriak, & Siuzdak, 1999) . Furthermore, these matrix-free ionization platforms were used to successfully image spatial distributions of metabolites and lipids in mouse brain tissue sections (Greving, Patti, & Siuzdak, 2011; Nemes, Woods, & Vertes, 2010; Wiseman, Ifa, Song, & Cooks, 2006; Yanes et al., 2009) . Among these, laser desorption ionization (LDI) from a silicon nanopost array (NAPA) has emerged as a promising matrix-free LDI platform that offers broad molecular coverage, ultratrace sensitivity, and tissue imaging capabilities (Korte, Stopka, Morris, Razunguzwa, & Vertes, 2016; Stopka et al., 2016; Walker, Stolee, Pickel, Retterer, & Vertes, 2010; Walker, Stolee, & Vertes, 2012) . Furthermore, thanks to advancements in photolithography, these NAPAs can be structurally modified and tuned to provide localized electric field enhancements, producing higher ion yields, whereas simultaneously requiring lower laser fluences (Morris et al., 2015; Stopka et al., 2018) .
In this work, we compare the abilities of NAPA-MS and MALDI-MS with two common matrices to ionize and image various lipid classes from pure standards and mouse brain tissue sections. To characterize the differences in ionization efficiencies, relative quantitation was used to compare the lipid signal from standards and from the complex matrix of mouse brain tissue.
| MATERIALS AND METHODS

| Chemicals
LC-MS grade solvents methanol (MeOH; catalog no. A452-4), chloroform (catalog no. C6704-4), isopropyl alcohol (IPA; catalog no. A461-4), acetonitrile (catalog no. A955-4), and water (catalog no. W6-212) were purchased from Fisher Scientific (Hampton, NH).
Lipid standards 1,2-dielaidoyl-sn-glycero-3-phosphocholine (PC; catalog no. 850376), 1-(1Z-octadecenyl)-2-docosahexaenoyl-snglycero-3-phosphoethanolamine (PEp; catalog no. 852806), 1-stearoyl-2-arachidonoyl-sn-glycero-3-phosphoethanolamine (PE; cata- 
| Fabrication of NAPA imaging chips
The fabrication of silicon nanoposts have been described elsewhere For matrix deposition in MALDI-MSI experiments, an airbrush (TS-100D, Paasche, Chicago, IL) was used to spray 100 mg/ml DHB in 60% MeOH and 12.5 mg/ml 9-AA in 90% MeOH in positive and negative ion mode operation, respectively. For uniform coverage, 10-15 cycles consisting of 10 s spraying followed by 30 s drying were used for DHB deposition, whereas as 25-30 cycles were used for 9-AA.
| Imaging data acquisition and processing
A MALDI-LTQ-Orbitrap XL mass spectrometer (Thermo Scientific, San Jose, CA) was used to acquire all MS and MSI data. Silicon NAPA imaging chips containing tissue sections were secured to a MALDI stainless steel plate using double-sided carbon tape (Ted Pella, Inc., Redding, CA), and inserted into the instrument. All tissue sections were registered by the instrument using the tissue imaging function.
The laser spot size at the sample surface was~100 × 80 μm and a raster step size of 100 μm was used throughout. To improve sensitivity, ions from multiple laser shots were collected in the ion trap before they were transferred to the orbitrap analyzer. 
| Tissue extraction and UPLC-MS/MS
Brain lipid extracts were prepared by placing intact mouse brain into a 5 ml centrifuge tube containing 2 ml of 70% methanol (chilled to Mass spectra were acquired from the m/z 150-1,800 region in the orbitrap mass analyzer with a resolving power setting of 30,000.
Tandem MS spectra were acquired in a data dependent fashion by selecting the most intense ion between m/z 350-1,000 in the MS master scan. After MS/MS acquisition, ions were excluded from selection for 10 s. Selected precursor ions were isolated with an m/z window of AE1 and fragmented using higher-energy collisional induced dissociation with a normalized collision energy of 25.
UPLC-MS/MS data were processed using MSconvert and mzMINE (version 2.23, RRID:SCR_012040) before being imported into LipidMatch for identification (Koelmel et al., 2017) . Lipid identifications were accepted for compounds which exhibited a precursor ion m/z error ≤10 mDa and tandem MS peaks corresponding to matching fatty acid chain lengths.
| RESULTS
To assess the ionization efficiencies for both NAPA-and MALDI-MS platforms, a solution containing six different lipid standards (HexCer, PC, PE, PEp, SM, and ST) was analyzed by both methods. For MALDI, matrices DHB and 9-AA were selected for the analysis of lipid standards in positive and negative ion mode, respectively. A range of laser fluences were tested to determine the optimal signal intensity of was found to be localized to both the cerebellar cortex, and to a lesser extent, the medulla (Figure 3g) . A corresponding plasmalogen, PE (40:6p), was predominantly found in the cerebellar cortex ( Figure 3c ).
The combined images in Figure 3d , h, which are combined from the chemical images to their left, highlight the specific regions where individual lipids dominate among the species detected in these experiments.
For a more in-depth comparison of lipid signal intensities and molecular coverage, spectra from the same region of the brain tissue were taken and analyzed by both the NAPA and MALDI platforms.
In positive ion mode, five adjacent MS scans (1 pixel/scan) localized to the cortex were compared. In negative ion mode, due to the overall lower signal, four averaged MS scans (1 scan/pixel) from five adjacent areas localized to the medulla were compared. In positive ion mode (Figure 4a ), the signal intensity is considerably stronger for NAPA compared to MALDI, especially for HexCer, PE, and PA. In and PA were represented in the NAPA spectra by 8, 22, 9, and 13, species, respectively, whereas in the MALDI spectra the same lipids were present at 1, 14, 15, and 16, respectively. In negative ion mode, the number of HexCer, PE, PC, PA, FA, and ST species detected by NAPA were 4, 18, 0, 1, 3, and 2, respectively, whereas MALDI identified 1, 4, 5, 2, 5, and 7 species, respectively. The complete list of confirmed and tentatively assigned lipids detected between both platforms can be found in Tables 1 and 2 .
| DISCUSSION
Currently, an extensive amount of MALDI-MSI studies exists that have investigated lipids in mouse brain tissue sections, demonstrating remarkable capabilities for the detection and imaging of phospholipids such as PC, PI, PE, and PS (Burnum et al., 2009; Murphy, Hankin, & Barkley, 2009; Puolitaival, Burnum, Cornett, & Caprioli, 2008) . Furthermore, MALDI-MSI has been used to detect and spatially map out changes in natural abundances of PC and ST lipid classes in a mouse model of Alzheimer's disease (Hong et al., 2016 (Watanabe et al., 1997; Watanabe, Sato, Yonekawa, Kleihues, & Ohgaki, 1996) . Lipidomics studies investigating the p53 genetic mutation found statistically significant changes in PEp and
HexCer levels localized to areas of cancerous brain tissue such as the hypothalamus and hippocampus (Lee et al., 2016) . Additionally, terminal neurological diseases such as Alzheimer's disease have been found to result in significant decreases in PE and increases in HexCer localized to the prefrontal cortex (Chan et al., 2012) . Reduced levels of PEp in the cortex have also been associated with Alzheimer's disease and adrenoleukodystrophy, a debilitating neurological disease (Grimm et al., 2011; Khan, Singh, & Singh, 2008) . With its enhanced ionization of these lipid species, NAPA-LDI-MSI has the potential to provide additional insight into these highly localized metabolic disruptions and their role in disease progression. enters the plume with significant amounts of matrix material. The acidic (e.g., DHB) or basic (e.g., 9-AA) matrix facilitates proton exchange to generate ions from desorbed analyte molecules.
In NAPA-LDI-MSI, the tissue section to be analyzed is placed on top of the NAPA. During analysis, the laser radiation penetrates through the tissue and is absorbed by the underlying nanoposts. Rapid heating of the nanoposts causes volatilization of a significant amount of the deposited material, and the plume is composed primarily of this ejected sample. The reduced availability of proton donors and increased availability of alkali metal cations (Na + and K + ) from the desorbed tissue favors generation of metal adduct ions and the detection of species which form stable alkali metal adducts. This hypothesis is consistent with the predominance of alkali metal adduct ions in the positive mode NAPA data found in Table 1 .
| CONCLUSIONS
Our results show that NAPA-LDI-MSI offers enhanced ionization of certain lipid classes including PE, PEp, and HexCer that are difficult to detect using traditional MALDI matrices and have important roles in signaling and disease. Furthermore, given the uniformity of the nanofabricated NAPA imaging chips, this platform offers the possibility to perform higher resolution imaging without specialized matrix deposi- authors and should not be interpreted as representing the official policies, either expressed or implied, of the Army Research Office, DARPA, or the U.S. Government. The U.S. Government is authorized to reproduce and distribute reprints for Government purposes notwithstanding any copyright notation hereon.
